Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The randomized controlled clinical treatment trial demonstrated that the administration of Bifidobacterium breve Yakult combined with Galactooligosaccharides (GOS) and Lacticaseibacillus casei Shirota did not significantly change inflammatory markers when compared to the control group. However, it did lead to improvements in the gut environment. These improvements were especially noticeable in obese patients with type 2 diabetes, indicating a partial enhancement of gut health through the use of syn…